Reveals a novel prognostic model using glycolysis-associated lncRNAs in osteosarcoma, suggesting improved risk assessment for patients.
This study revealed the prognostic value of glycolytic-associated lncRNAs in osteosarcoma. The novel glycolysis-associated lncRNA-based model may offer new insights into prognostic evaluation and clinical risk decision for patients with osteosarcoma.
No takes yet. Share an insight, caveat, or question.
Ma et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: